Related Experiment Video

Updated: Oct 7, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Combinatorial nanotherapeutics: rewiring, then killing, cancer cells

Ronnie H Fang1, Liangfang Zhang2

  • 1Department of NanoEngineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA.

Science Signaling
|May 15, 2014
PubMed

Insights

This study introduces a novel nanoparticle system for sequential drug delivery to combat cancer therapy resistance. The system first sensitizes cancer cells and then enhances the efficacy of a genotoxic drug for improved tumor cell killing.

Area of Science:

  • Oncology
  • Nanotechnology
  • Molecular Biology

Background:

  • Cancer cells exhibit inherent resilience and develop resistance to therapies, leading to unfavorable patient prognoses.
  • Advanced analytical and computational tools have elucidated the impact of molecularly targeted drugs on cancer cell biochemical networks, guiding treatment design.
  • Overcoming therapeutic resistance is a critical challenge in cancer treatment.

Purpose of the Study:

  • To develop and demonstrate a nanoparticle system for sequential drug delivery to overcome cancer therapy resistance.
  • To sensitize cancer cells to apoptosis using targeted pathway inhibition.
  • To enhance the efficiency of genotoxic cancer drugs by exploiting cancer cell vulnerability.

Main Methods:

  • Development of a nanoparticle system for controlled, sequential drug release.
  • Utilizing a first drug to inhibit an oncogenic pathway and sensitize cancer cells.
  • Employing a second, genotoxic drug to induce apoptosis in sensitized cancer cells.

Main Results:

  • The nanoparticle system successfully delivered two drugs sequentially.
  • The first drug effectively sensitized cancer cells to apoptosis.
  • The sequential delivery strategy enhanced the killing efficiency of the genotoxic drug against cancer cells.

Conclusions:

  • Sequential drug delivery via nanoparticles offers a promising strategy to overcome cancer therapy resistance.
  • This approach can improve the efficacy of genotoxic agents by targeting cancer cell vulnerabilities.
  • Nanoparticle-mediated sequential therapy holds potential for improving patient outcomes in cancer treatment.

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...